Literature DB >> 32828983

Modulation of the Association of Hypobicarbonatemia and Incident Kidney Failure With Replacement Therapy by Venous pH: A Cohort Study.

Sachio Kajimoto1, Yusuke Sakaguchi2, Yuta Asahina1, Jun-Ya Kaimori3, Yoshitaka Isaka1.   

Abstract

RATIONALE &
OBJECTIVE: Studies showing an association between lower bicarbonate levels and worse kidney disease prognosis have not accounted for the influence of pH. It remains unknown whether this association is consistent across a wide range of blood pH values. This study sought to assess how pH modifies the relationship between hypobicarbonatemia and incident kidney failure requiring kidney replacement therapy (KFRT). STUDY
DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 1,058 Japanese patients with estimated glomerular filtration rates<60mL/min/1.73m2. EXPOSURE: Baseline venous bicarbonate levels and venous pH. OUTCOME: KFRT defined as initiation of kidney replacement therapy (hemodialysis, peritoneal dialysis, and kidney transplantation). ANALYTICAL APPROACH: Cox proportional hazards model assessing the interaction between baseline bicarbonate levels and venous pH on incident KFRT.
RESULTS: In the lowest bicarbonate quartile (≤21.5 mEq/L), 59% of patients had acidemia (pH<7.32), whereas 38% had venous pH within the normal range and 3% had alkalemia (pH>7.42). During a median follow-up of 3.0 years, 374 patients developed KFRT. Venous pH modified the association between bicarbonate level and rate of KFRT (P for interaction=0.04). After adjustment for potential confounders, including capacity for respiratory compensation, the lowest (vs the highest) bicarbonate quartile was associated with a 2.29-fold (95% CI, 1.10-4.77; P=0.03) higher rate of KFRT among patients with acidemia (pH<7.32). In contrast, among patients without acidemia (pH≥7.32), no significant association was found between bicarbonate level and KFRT. In an exploratory analysis, patients with higher respiratory compensation capacity had a lower rate of KFRT (HR per 0.1 increase in respiratory compensation capacity, 0.90; 95% CI, 0.87-0.94; P<0.001). LIMITATIONS: Observational study design; blood gas measurements were performed in a select patient population.
CONCLUSIONS: Venous pH modified the association of hypobicarbonatemia with progression of chronic kidney disease to KFRT. Measurement of venous pH may be valuable for identifying patients with chronic kidney disease and hypobicarbonatemia and may inform treatment.
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metabolic acidosis; acid load; acid-base disturbance; acidemia; alkali therapy; bicarbonate level; blood gas analysis; chronic kidney disease (CKD); hypobicarbonatemia; kidney disease progression; kidney failure with replacement therapy (KFRT); pH; renal replacement therapy (RRT); respiratory compensation

Mesh:

Substances:

Year:  2020        PMID: 32828983     DOI: 10.1053/j.ajkd.2020.06.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort study.

Authors:  Yuta Asahina; Yusuke Sakaguchi; Sachio Kajimoto; Koki Hattori; Yohei Doi; Tatsufumi Oka; Jun-Ya Kaimori; Yoshitaka Isaka
Journal:  Clin Kidney J       Date:  2021-12-16

2.  Assessment of Acid-Base Status: Beyond Serum Bicarbonate.

Authors:  Jeffrey A Kraut; Kalani L Raphael
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-04       Impact factor: 10.614

Review 3.  Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease.

Authors:  Pedro H Imenez Silva; Robert Unwin; Ewout J Hoorn; Alberto Ortiz; Francesco Trepiccione; Rikke Nielsen; Vesna Pesic; Gaye Hafez; Denis Fouque; Ziad A Massy; Chris I De Zeeuw; Giovambattista Capasso; Carsten A Wagner
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

4.  Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.

Authors:  Vandana S Mathur; Donald E Wesson; Navdeep Tangri; Elizabeth Li; David A Bushinsky
Journal:  BMC Nephrol       Date:  2022-02-25       Impact factor: 2.388

5.  Diagnosing metabolic acidosis in chronic kidney disease: importance of blood pH and serum anion gap.

Authors:  Jun-Ya Kaimori; Yusuke Sakaguchi; Sachio Kajimoto; Yuta Asahina; Tatsufumi Oka; Koki Hattori; Yohei Doi; Yoshitaka Isaka
Journal:  Kidney Res Clin Pract       Date:  2022-01-10

Review 6.  Kidney metabolism and acid-base control: back to the basics.

Authors:  Pedro Henrique Imenez Silva; Nilufar Mohebbi
Journal:  Pflugers Arch       Date:  2022-05-05       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.